e-learning
resources
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?
Gabriele Biondi, Giovanni Sotgiu, Simone Dore, Paola Molicotti, Melania Ruggeri, Stefano Aliberti, Rosanna Satta
Source:
ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gabriele Biondi, Giovanni Sotgiu, Simone Dore, Paola Molicotti, Melania Ruggeri, Stefano Aliberti, Rosanna Satta. Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?. ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Developing the pneumonia-optimized ratio for community-acquired pneumonia: an easy, inexpensive and accurate prognostic biomarker
Salivary SLPI and disease severity in bronchiectasis
Relationship of respiratory disorders of sleep with cognitive impairment and neurological diseases
Related content which might interest you:
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019
Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018
Year: 2019
Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012
New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases
Year: 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Guideline 2020
Year: 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Year: 2020
Crohn‘s disease or extrapulmonary tuberculosis?
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs
Source: Eur Respir J , 49 (4) 1700374; DOI: 10.1183/13993003.00374-2017
Year: 2017
Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection.
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020
Year: 2021
Extrapulmonary tuberculosis and simultaneous tuberculosis – possible indices for general population‘s health evaluation
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada
Source: Eur Respir J 2011; 37: 1158-1165
Year: 2011
Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008
Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept